- Home
- FGEN vs CMBM Comparison
FGEN vs CMBM Comparison
Compare FGEN & CMBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGEN
- CMBM
- Stock Information
- Founded
- FGEN 1993
- CMBM 2011
- Country
- FGEN United States
- CMBM United States
- Employees
- FGEN N/A
- CMBM N/A
- Industry
- FGEN Biotechnology: Pharmaceutical Preparations
- CMBM Radio And Television Broadcasting And Communications Equipment
- Sector
- FGEN Health Care
- CMBM Technology
- Exchange
- FGEN Nasdaq
- CMBM Nasdaq
- Market Cap
- FGEN 33.5M
- CMBM 9.6M
- IPO Year
- FGEN 2014
- CMBM 2019
- Fundamental
- Price
- FGEN $5.61
- CMBM $0.40
- Analyst Decision
- FGEN Strong Buy
- CMBM Strong Buy
- Analyst Count
- FGEN 1
- CMBM 2
- Target Price
- FGEN $250.00
- CMBM $5.50
- AVG Volume (30 Days)
- FGEN 60.2K
- CMBM 1.0M
- Earning Date
- FGEN 08-05-2025
- CMBM 08-07-2025
- Dividend Yield
- FGEN N/A
- CMBM N/A
- EPS Growth
- FGEN N/A
- CMBM N/A
- EPS
- FGEN N/A
- CMBM N/A
- Revenue
- FGEN $6,996,000.00
- CMBM $172,215,000.00
- Revenue This Year
- FGEN N/A
- CMBM N/A
- Revenue Next Year
- FGEN N/A
- CMBM $17.87
- P/E Ratio
- FGEN N/A
- CMBM N/A
- Revenue Growth
- FGEN N/A
- CMBM N/A
- 52 Week Low
- FGEN $4.50
- CMBM $0.23
- 52 Week High
- FGEN $38.25
- CMBM $2.50
- Technical
- Relative Strength Index (RSI)
- FGEN 39.07
- CMBM 56.74
- Support Level
- FGEN $4.85
- CMBM $0.38
- Resistance Level
- FGEN $5.77
- CMBM $0.47
- Average True Range (ATR)
- FGEN 0.57
- CMBM 0.04
- MACD
- FGEN -0.02
- CMBM 0.01
- Stochastic Oscillator
- FGEN 31.67
- CMBM 70.13
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.
About CMBM Cambium Networks Corporation
Cambium Networks Corp provides wireless broadband networking infrastructure solutions for network operators, including medium-sized wireless Internet service providers, enterprises, and government agencies. The company geographically operates in North America; Europe, Middle East and Africa; Caribbean and Latin America; and Asia Pacific. It derives maximum revenue from North America.